Onderneming Virpax Pharmaceuticals, Inc.
Aandelen
VRPX
US9282512063
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,5024 USD | +1,07% |
|
-11,88% | -84,30% |
22/05 | VIRPAX PHARMACEUTICALS, INC. : Maxim haalt aandeel van kooplijst | ZM |
15/05 | Virpax prijst openbaar aanbod van aandelen, warrants; aandelen tuimelen | MT |
Vakgebied
Aantal werknemers: 7
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Gudin
FOU | Founder | 58 | 01-01-17 |
Gerald Bruce
CEO | Chief Executive Officer | 68 | 01-08-17 |
Vinay Shah
DFI | Director of Finance/CFO | 62 | 20-06-23 |
Sheila Mathias
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gerald Bruce
CEO | Chief Executive Officer | 68 | 01-08-17 |
Jeffrey Gudin
FOU | Founder | 58 | 01-01-17 |
Barbara Ruskin
BRD | Director/Board Member | - | 24-03-23 |
Eric Floyd
CHM | Chairman | 62 | 01-01-17 |
Jerrold Sendrow
BRD | Director/Board Member | 79 | 01-01-17 |
Vanila Singh
BRD | Director/Board Member | 53 | 01-06-20 |
Director/Board Member | 60 | 01-01-17 | |
Michael Dubin
BRD | Director/Board Member | 68 | 26-07-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 2 741 600 | 2 440 340 ( 89,01 %) | 0 | 89,01 % |
Bedrijfsgegevens
![Adres Virpax Pharmaceuticals, Inc.(VRPX)](https://cdn.zonebourse.com/static/address/119073351.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-84,30% | 588K | |
+38,36% | 52,73 mld. | |
+38,03% | 39 mld. | |
-8,63% | 38,52 mld. | |
+25,46% | 30,38 mld. | |
-11,17% | 26,39 mld. | |
+11,44% | 26,08 mld. | |
+45,09% | 14,15 mld. | |
+32,93% | 12,6 mld. | |
-5,30% | 11,51 mld. |
- Beurs
- Aandelen
- Koers VRPX
- Onderneming Virpax Pharmaceuticals, Inc.